Company profilePharmaceutical#80 of 1,318 in Pakistan1 DRAP alert

FRIENDS PHARMA (PVT) LTD

Pharmaceutical company · 191 brands · 172 molecules

Ranked #146 of 207 companies in Quinolone Antibacterials

191 registered products 64 pharmaceutical brands 172 distinct molecules 1 DRAP alert

Company overview

191
registered products
64
pharmaceutical brands
172
distinct molecules
2
therapeutic classes
1
DRAP alerts

FRIENDS PHARMA (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 191 product registrations across 172 distinct molecules. It is the 80th largest registrant in Pakistan by product count, and ranks 146th of 207 in Quinolone Antibacterials. Its portfolio is concentrated in Quinolone Antibacterials and Agents Against Amoebiasis And Other Protozoal Diseases. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by FRIENDS

82 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

80
ceilings with an approval date
8
not revised in 2+ years
2024
oldest approval year
20248
202569
20263
Longest without revision

Top molecules by brand count

Ciprofloxacin10 brands
Levofloxacin7 brands
Artemether6 brands
Clotrimazole6 brands
Azithromycin5 brands
Cephalexin5 brands
Paracetamol5 brands
Metformin4 brands
Omeprazole4 brands

Therapeutic classes

Quinolone Antibacterials · 1Agents Against Amoebiasis And Other Protozoal Diseases · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official155 products · Rs 4.59 – Rs 1,615.68
DVAGO1 products · Rs 105.21 – Rs 105.21
Median across source: Rs 271.6

Regulatory record

1 alert in the DRAP feed we track.

113. Recall Alert (Class-I) – Substandard Drug Products (Human)
2025-11-20

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NEUTRO PHARMA (PVT) LTD. holds 95 molecules not in this portfolio
AcetylcysteineAmikacinAnastrazoleAnastrozoleAntimonyAripiprazole
BIO LABS (PVT) LTD. holds 108 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtesunateAtorvastatin
MEDIATE PHARMACEUTICALS (PVT) LTD holds 83 molecules not in this portfolio
AlendronateAmlodipineAmoxicillinAmpicillinAmpicillin BaseAnastrozole

Get the full profile for FRIENDS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.